UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
April 26, 2002
--------------
SANGUI BIOTECH INTERNATIONAL, INC.
----------------------------------
(Exact Name of Registrant as Specified in its Charter)
Colorado
----------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-21271 84-1330732
------------------------- ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
1508 Brookhollow Drive, Suite 354, Santa Ana, California 92705
-----------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(Registrant's telephone number, including area code) - (714) 429-7807
---------------------------------------------------------------------
INFORMATION TO BE INCLUDED IN THE REPORT
ITEM 5. OTHER EVENTS
A press release regarding departure of the officers of the Company was issued on
May 8, 2002, a copy of which is attached hereto as Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) EXHIBITS
99.1 Press Release dated May 8, 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SANGUI BIOTECH INTERNATIONAL, INC.
Dated: May 8, 2002 By: /s/ Wolfgang Barnikol
---------------------------------
Wolfgang Barnikol
President and CEO
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------- -----------
99.1 Press Release dated May 8, 2002.